Royal Brompton Hospital is the largest specialist heart and lung medical centre in the United Kingdom. It is managed by Guy's and St Thomas' NHS Foundation Trust.

During the past decade, Royal Brompton Hospital/NHLI Imperial College London conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Brompton Hospital/NHLI Imperial College London" #1 collaborator was "Royal Brompton & Harefield NHS Foundation Trust" with 2 trials as a collaborator, "Barcelona Institute for Global Health" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Gene Logic" with 1 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Royal Brompton Hospital/NHLI Imperial College London" are "COPD" (4 trials), "Emphysema" (4 trials), "Chronic Bronchitis" (3 trials), "ASTHMA" (1 trials) and "Asthma" (1 trials). Many other conditions were trialed in "Royal Brompton Hospital/NHLI Imperial College London" in a lesser frequency.

Most popular intervention types in "Royal Brompton Hospital/NHLI Imperial College London" are "Device" (2 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Coaching program" (1 trials), "Continous Positive Airway Pressure" (1 trials), "Control Group" (1 trials), "RePneu Lung Volume Reduction Coil System" (1 trials) and "SALBUTAMOL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Brompton Hospital/NHLI Imperial College London" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Royal Brompton Hospital/NHLI Imperial College London". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Royal Brompton Hospital/NHLI Imperial College London, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Brompton Hospital/NHLI Imperial College London, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".